Skip to main content
. 2024 Jun 18;11:1432559. doi: 10.3389/fmed.2024.1432559

Table 1.

Main results of descriptive analysis of DS and control group excluding strong outliers.

DS (n = 164) Control (n = 54)
THF (ng/mL) 5-methyl-THF (ng/mL) 5-formyl-THF (pg/mL) SAH (ng/mL) SAM (ng/mL) THF (ng/mL) 5-methyl-THF (ng/mL) 5-formyl-THF (pg/mL) SAH (ng/mL) SAM (ng/mL)
Valid n = 108 140 79 94 24 41 34 21 19 15
Missing n = 56 24 85 70 140 13 20 33 35 39
Mean 41.574 50.247 151.675 6.588 10.308 57.783 45.369 145.917 1.911 8.022
Median 33.955 49.766 137.955 6.298 9.514 51.471 42.744 139.144 1.736 5.222
SD 29.414 9.358 29.300 2.923 4.237 32.645 12.301 15.413 1.213 6.362

The values of subjects with Down syndrome (DS) are reported on the left of the table and the values of normal control subjects (control) are reported on the right of the table. For each metabolite the number (n) of plasma samples valid or missing are reported. Also the mean, median and standard deviation (SD) values are shown. The detailed results of descriptive analysis with and without strong outliers are shown in Supplementary Table 6.